Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
S. Fieuws, and G. Verbeke. Statistics in medicine, 23 (20):
3093-104(October 2004)4302<m:linebreak></m:linebreak>PUBM: Print; CI: Copyright 2004; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Mixed models.
G. Stewart, D. Altman, L. Askie, L. Duley, M. Simmonds, and L. Stewart. PloS one, 7 (10):
e46042(January 2012)7049<m:linebreak></m:linebreak>JID: 101285081; OID: NLM: PMC3463584; 2012/06/06 received; 2012/08/28 accepted; 2012/10/03 epublish; ppublish;.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
T. Cleophas, A. Zwinderman, and B. van Ouwerkerk. American journal of therapeutics, 19 (1):
e1-7(January 2012)21048432<br/><br/>JID: 9441347; ppublish;<br/><br/>Mixed models; Dades longitudinals; SPSS.